NASDAQ:PDEX Pro-Dex (PDEX) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PDEX Stock Alerts $18.46 -0.04 (-0.22%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$18.40▼$18.7250-Day Range$16.50▼$19.0052-Week Range$14.51▼$22.99Volume5,650 shsAverage Volume7,913 shsMarket Capitalization$64.79 millionP/E Ratio24.61Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Pro-Dex alerts: Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Pro-Dex Stock (NASDAQ:PDEX)Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Read More PDEX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PDEX Stock News HeadlinesApril 23, 2024 | msn.comWhat is Samsung DeX and how does it work?April 19, 2024 | money.usnews.comPro-Dex Inc. (co)April 25, 2024 | Insider Financial (Ad)Thousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.April 9, 2024 | msn.comAutoPro X accessory will bring Samsung DeX to your vehicleApril 2, 2024 | benzinga.comVicarious Surgical Stock (NYSE:RBOT), Quotes and News SummaryMarch 15, 2024 | seekingalpha.comMonogram Orthopaedics reports FY resultsFebruary 22, 2024 | finance.yahoo.comThe Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire ConfidenceFebruary 8, 2024 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month ResultsApril 25, 2024 | Insider Financial (Ad)Thousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.January 26, 2024 | finance.yahoo.comPro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five yearsDecember 30, 2023 | finance.yahoo.comIs Pro-Dex, Inc.'s (NASDAQ:PDEX) Latest Stock Performance A Reflection Of Its Financial Health?November 14, 2023 | finance.yahoo.comHere’s Why You Should Consider Buying Pro-Dex (PDEX) SharesNovember 10, 2023 | morningstar.comPro-Dex Inc PDEXNovember 2, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2024 First Quarter ResultsNovember 2, 2023 | finance.yahoo.comPro-Dex Inc (PDEX) Reports 8% Increase in Q1 Fiscal 2024 Net Sales, Despite Net Loss of $615,000October 26, 2023 | finanznachrichten.deStock Day Media: Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastOctober 26, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day PodcastOctober 15, 2023 | finance.yahoo.comPro-Dex Inc (PDEX) Reports Fiscal 2023 Fourth Quarter and Full-Year ResultsOctober 13, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year ResultsOctober 4, 2023 | morningstar.comNorth American Morning Briefing: S&P 500 Futures -2-August 7, 2023 | finance.yahoo.comPro-Dex's (NASDAQ:PDEX) Returns Have Hit A WallJune 29, 2023 | finance.yahoo.comAt US$18.26, Is It Time To Put Pro-Dex, Inc. (NASDAQ:PDEX) On Your Watch List?June 5, 2023 | finanznachrichten.deStock Day Media: Pro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day PodcastJune 5, 2023 | finance.yahoo.comPro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day PodcastMay 30, 2023 | finance.yahoo.comPro-Dex (NASDAQ:PDEX) shareholders have earned a 23% CAGR over the last five yearsMay 4, 2023 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month ResultsApril 20, 2023 | seekingalpha.comPDEX Pro-Dex, Inc.See More Headlines Receive PDEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/08/2024Today4/25/2024Next Earnings (Estimated)5/02/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:PDEX CUSIPN/A CIK788920 Webwww.pro-dex.com Phone(949) 769-3200Fax949-769-3281Employees145Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.75 Trailing P/E Ratio24.67 Forward P/E RatioN/A P/E GrowthN/ANet Income$7.07 million Net Margins5.59% Pretax Margin8.28% Return on Equity8.97% Return on Assets5.40% Debt Debt-to-Equity Ratio0.26 Current Ratio3.66 Quick Ratio2.16 Sales & Book Value Annual Sales$46.09 million Price / Sales1.41 Cash Flow$2.21 per share Price / Cash Flow8.37 Book Value$8.91 per share Price / Book2.08Miscellaneous Outstanding Shares3,510,000Free Float2,015,000Market Cap$64.94 million OptionableNot Optionable Beta0.60 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Richard Lee Van Kirk Jr. (Age 63)CEO, President, COO & Director Comp: $418.61kMs. Alisha K. Charlton (Age 54)CFO & Corporate Secretary Comp: $297.61kKey CompetitorsMonogram OrthopaedicsNASDAQ:MGRMSEP AcquisitionNASDAQ:SEPAenVVeno MedicalNASDAQ:NVNOAutonomix MedicalNASDAQ:AMIXSensus HealthcareNASDAQ:SRTSView All CompetitorsInstitutional OwnershipLSV Asset ManagementSold 5,800 shares on 2/6/2024Ownership: 0.729%View All Institutional Transactions PDEX Stock Analysis - Frequently Asked Questions How have PDEX shares performed in 2024? Pro-Dex's stock was trading at $17.52 at the start of the year. Since then, PDEX shares have increased by 5.4% and is now trading at $18.46. View the best growth stocks for 2024 here. Are investors shorting Pro-Dex? Pro-Dex saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 21,400 shares, an increase of 44.6% from the March 31st total of 14,800 shares. Based on an average daily trading volume, of 8,100 shares, the days-to-cover ratio is currently 2.6 days. Currently, 0.9% of the shares of the stock are short sold. View Pro-Dex's Short Interest. When is Pro-Dex's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our PDEX earnings forecast. How were Pro-Dex's earnings last quarter? Pro-Dex, Inc. (NASDAQ:PDEX) announced its earnings results on Thursday, February, 8th. The medical instruments supplier reported $0.14 earnings per share (EPS) for the quarter. The medical instruments supplier earned $12.59 million during the quarter. Pro-Dex had a net margin of 5.59% and a trailing twelve-month return on equity of 8.97%. What is Michael J. Berthelot's approval rating as Pro-Dex's CEO? 3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees. What other stocks do shareholders of Pro-Dex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH). How do I buy shares of Pro-Dex? Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PDEX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
